FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3155486515> ?p ?o ?g. }

• W3155486515 endingPage "82" @default.
• W3155486515 startingPage "73" @default.
• W3155486515 abstract "Objective : to evaluate the pharmacokinetics of nadroparin and dalteparin in thrombosis complicating the treatment of children with malignant neoplasms. Materials and methods . The results of 52 pharmacokinetic studies performed in 34 patients with malignant neoplasms, whose treatment was complicated by venous thrombosis, were analyzed. The age of the patients is from 7 to 18 years, he median is 14.5 years. Depending on the value of daily dose and type of heparin administered, the results of pharmacokinetic studies were divided into 6 groups. Dalteparin sodium: during period of chemotherapy induced thrombocytopenia, subcutaneous injection at a dose of 51.0 (40.0-72.0) anti Xa IU/kg every 12 hours - 6 studies; subcutaneous injection every 12 hours at a dose of 100.5 (91.0-141.0) anti Xa IU/kg - 18 observations; long-term continuous administration at a constant rate at a daily dose of 201.0 (180.0-265.0) anti Xa IU/kg - 6 pharmacokinetic observations. Nadroparin calcium: 62.0 (53.0-71.0) anti Xa IU/kg every 12 hours - 6 studies; 93.5 (80.0-117.0) anti Xa IU/kg every 12 hours - 10 observations; subcutaneous injection at a dose of 203.0 (170.0-236.0) anti Xa IU/kg once a day - 6 pharmacokinetic observations. Results . At steady-state, the area under the pharmacokinetic curve (AUC) of dalteparin and nadroparin, regardless of the mode of administration, depended on the maximum specific activity and half-life. No relationship was found for dalteparin between AUC and endogenous creatinine clearance. In contrast to dalteparin, the AUC after administration of na-droparin was closely related to endogenous creatinine clearance. The increase in chronometric indices indirectly reflected the presence of an anticoagulant in the blood, but did not allow an objective assessment of therapeutic effect achievement, recorded by the degree of thrombin generation inhibition. Conclusion . There were no significant advantages of nadroparin compared with dalteparin when using in comparable doses in the case of venous thrombosis, complicated the treatment of children with malignant neoplasms. Subcutaneous administration of 50 % nadroparin calcium daily dose with 12 hours interval is preferred over a single administration of 100 % daily dose every 24 hours. It is mandatory to monitor the administration of low molecular weight heparins in children with oncological diseases in order to make a decision on the adequacy of anticoagulant dose to the therapeutic range." @default.
• W3155486515 created "2021-04-26" @default.
• W3155486515 creator A5009373463 @default.
• W3155486515 creator A5010630577 @default.
• W3155486515 creator A5016873587 @default.
• W3155486515 creator A5029396953 @default.
• W3155486515 creator A5071602993 @default.
• W3155486515 date "2021-04-14" @default.
• W3155486515 modified "2023-10-14" @default.
• W3155486515 title "Pharmacokinetics of low molecular weight heparins in thrombosis, complicate the treatment of children with cancer" @default.
• W3155486515 cites W1550111394 @default.
• W3155486515 cites W1976249987 @default.
• W3155486515 cites W1989589111 @default.
• W3155486515 cites W2009247019 @default.
• W3155486515 cites W2021352253 @default.
• W3155486515 cites W2038706245 @default.
• W3155486515 cites W2106459062 @default.
• W3155486515 cites W2108043885 @default.
• W3155486515 cites W2168589564 @default.
• W3155486515 cites W2271119595 @default.
• W3155486515 cites W2277019582 @default.
• W3155486515 cites W2289214695 @default.
• W3155486515 cites W2300666200 @default.
• W3155486515 cites W2347081948 @default.
• W3155486515 cites W2902418274 @default.
• W3155486515 doi "https://doi.org/10.17650/1818-8346-2021-16-1-73-82" @default.
• W3155486515 hasPublicationYear "2021" @default.
• W3155486515 type Work @default.
• W3155486515 sameAs 3155486515 @default.
• W3155486515 citedByCount "1" @default.
• W3155486515 countsByYear W31554865152023 @default.
• W3155486515 crossrefType "journal-article" @default.
• W3155486515 hasAuthorship W3155486515A5009373463 @default.
• W3155486515 hasAuthorship W3155486515A5010630577 @default.
• W3155486515 hasAuthorship W3155486515A5016873587 @default.
• W3155486515 hasAuthorship W3155486515A5029396953 @default.
• W3155486515 hasAuthorship W3155486515A5071602993 @default.
• W3155486515 hasBestOaLocation W31554865151 @default.
• W3155486515 hasConcept C112705442 @default.
• W3155486515 hasConcept C141071460 @default.
• W3155486515 hasConcept C2776884760 @default.
• W3155486515 hasConcept C2780011451 @default.
• W3155486515 hasConcept C2780868729 @default.
• W3155486515 hasConcept C42219234 @default.
• W3155486515 hasConcept C71924100 @default.
• W3155486515 hasConcept C98274493 @default.
• W3155486515 hasConceptScore W3155486515C112705442 @default.
• W3155486515 hasConceptScore W3155486515C141071460 @default.
• W3155486515 hasConceptScore W3155486515C2776884760 @default.
• W3155486515 hasConceptScore W3155486515C2780011451 @default.
• W3155486515 hasConceptScore W3155486515C2780868729 @default.
• W3155486515 hasConceptScore W3155486515C42219234 @default.
• W3155486515 hasConceptScore W3155486515C71924100 @default.
• W3155486515 hasConceptScore W3155486515C98274493 @default.
• W3155486515 hasIssue "1" @default.
• W3155486515 hasLocation W31554865151 @default.
• W3155486515 hasOpenAccess W3155486515 @default.
• W3155486515 hasPrimaryLocation W31554865151 @default.
• W3155486515 hasRelatedWork W2010347505 @default.
• W3155486515 hasRelatedWork W2154967465 @default.
• W3155486515 hasRelatedWork W2365903619 @default.
• W3155486515 hasRelatedWork W2371372815 @default.
• W3155486515 hasRelatedWork W2379497856 @default.
• W3155486515 hasRelatedWork W2395675806 @default.
• W3155486515 hasRelatedWork W2473481015 @default.
• W3155486515 hasRelatedWork W2552243206 @default.
• W3155486515 hasRelatedWork W2753486433 @default.
• W3155486515 hasRelatedWork W2801779377 @default.
• W3155486515 hasVolume "16" @default.
• W3155486515 isParatext "false" @default.
• W3155486515 isRetracted "false" @default.
• W3155486515 magId "3155486515" @default.
• W3155486515 workType "article" @default.